--Must See--

Bioinformatics Summer Internship 2024 With Hands-On-Training + Project / Dissertation - 30 Days, 3 Months & 6 Months Duration

Mitra Biotech Partners with Israeli Gotect Diagnostic

Mitra Biotech, founded in 2010, headquartered in Greater Boston and maintaining a significant research and laboratory presence in Bengaluru, has now announced a partnership with Gotect Diagnostic for the exclusive right to represent it in Israel.

Gotect is based in Tel Aviv, and supports technological and scientific innovation in the pursuit of improving patient health in Israel as well as other Mediterranean markets.

We’re proud and pleased to have secured a quality partner like Gotect to introduce CANscript into Israel,” said Mallik Sundaram, Mitra CEO and Co-Founder. “Together we look forward to helping inform the selection of effective treatments for Israeli cancer patients.

Mitra’s famed platform for powerful, individualized treatment response predictions — with exceptionally high correlation to clinical outcomes — recreates a patient’s own tumor microenvironment in vitro, measures multiple parameters to determine whether a tumor is responding to physician-selected treatments, and then converts these parameters into a single score that predicts clinical response to each of the physician-selected therapies. The platform, CANscript has been validated using thousands of cancer cases, with a published 90% overall correlation1 between the platform’s treatment predictions and actual clinical outcomes.

In search of the perfect burger. Serial eater. In her spare time, practises her "Vader Voice". Passionate about dance. Real Weird.